|
1
|
Munstermann U, Fritz G, Seitz G, Lu YP,
Schneider HR and Issinger OG: Casein kinase II is elevated in solid
human tumours and rapidly proliferating non-neoplastic tissue. Eur
J Biochem. 189:251–257. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ahmed K, Davis AT, Wang H, Faust RA, Yu S
and Tawfic S: Significance of protein kinase CK2 nuclear signaling
in neoplasia. J Cell Biochem Suppl. Suppl 35:S130–S135. 2000.
View Article : Google Scholar
|
|
3
|
Ruzzene M and Pinna LA: Addiction to
protein kinase CK2: A common denominator of diverse cancer cells?
Biochim Biophys Acta. 1804:499–504. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landesman-Bollag E, Romieu-Mourez R, Song
DH, Sonenshein GE, Cardiff RD and Seldin DC: Protein kinase CK2 in
mammary gland tumorigenesis. Oncogene. 20:3247–3257. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Woodhouse EC, Chuaqui RF and Liotta LA:
General mechanisms of metastasis. Cancer. 80 8 Suppl:S1529–S1537.
1997. View Article : Google Scholar
|
|
8
|
Patel D, Shukla S and Gupta S: Apigenin
and cancer chemoprevention: Progress, potential and promise
(review). Int J Oncol. 30:233–245. 2007.PubMed/NCBI
|
|
9
|
Shukla S and Gupta S: Apigenin-induced
cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and
loss of cyclin D1 associated retinoblastoma dephosphorylation in
human prostate cancer cells. Cell Cycle. 6:1102–1114. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shukla S and Gupta S: Suppression of
constitutive and tumor necrosis factor alpha-induced nuclear factor
(NF)-kappaB activation and induction of apoptosis by apigenin in
human prostate carcinoma PC-3 cells: Correlation with
down-regulation of NF-kappaB-responsive genes. Clin Cancer Res.
10:3169–3178. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen D, Landis-Piwowar KR, Chen MS and Dou
QP: Inhibition of proteasome activity by the dietary flavonoid
apigenin is associated with growth inhibition in cultured breast
cancer cells and xenografts. Breast Cancer Res. 9:R802007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Way TD, Kao MC and Lin JK: Degradation of
HER2/neu by apigenin induces apoptosis through cytochrome c release
and caspase-3 activation in HER2/neu-overexpressing breast cancer
cells. FEBS Lett. 579:145–152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JS, Eom JI, Cheong JW, Choi AJ, Lee
JK, Yang WI and Min YH: Protein kinase CK2alpha as an unfavorable
prognostic marker and novel therapeutic target in acute myeloid
leukemia. Clin Cancer Res. 13:1019–1028. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L and Hung MC: Sensitization of
HER-2/neu-overexpressing non-small cell lung cancer cells to
chemotherapeutic drugs by tyrosine kinase inhibitor emodin.
Oncogene. 12:571–576. 1996.PubMed/NCBI
|
|
15
|
Zou J, Luo H, Zeng Q, Dong Z, Wu D and Liu
L: Protein kinase CK2α is overexpressed in colorectal cancer and
modulates cell proliferation and invasion via regulating
EMT-related genes. J Transl Med. 9:972011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sarno S, Ruzzene M, Frascella P, Pagano
MA, Meggio F, Zambon A, Mazzorana M, Di Maira G, Lucchini V and
Pinna LA: Development and exploitation of CK2 inhibitors. Mol Cell
Biochem. 274:69–76. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Maira G, Brustolon F, Bertacchini J,
Tosoni K, Marmiroli S, Pinna LA and Ruzzene M: Pharmacological
inhibition of protein kinase CK2 reverts the multidrug resistance
phenotype of a CEM cell line characterized by high CK2 level.
Oncogene. 26:6915–6926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pagano MA, Andrzejewska M, Ruzzene M,
Sarno S, Cesaro L, Bain J, Elliott M, Meggio F, Kazimierczuk Z and
Pinna LA: Optimization of protein kinase CK2 inhibitors derived
from 4,5,6,7-tetrabromobenzimidazole. J Med Chem. 47:6239–6247.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakajima M, Welch DR, Belloni PN and
Nicolson GL: Degradation of basement membrane type IV collagen and
lung subendothelial matrix by rat mammary adenocarcinoma cell
clones of differing metastatic potentials. Cancer Res.
47:4869–4876. 1987.PubMed/NCBI
|
|
20
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin CW, Hou WC, Shen SC, Juan SH, Ko CH,
Wang LM and Chen YC: Quercetin inhibition of tumor invasion via
suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC
and Lee IS: Silibinin suppresses PMA-induced MMP-9 expression by
blocking the AP-1 activation via MAPK signaling pathways in MCF-7
human breast carcinoma cells. Biochem Biophys Res Commun.
354:165–171. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Newton AC: Regulation of protein kinase C.
Curr Opin Cell Biol. 9:161–167. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee SO, Jeong YJ, Kim M, Kim CH and Lee
IS: Suppression of PMA-induced tumor cell invasion by capillarisin
via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem
Biophys Res Commun. 366:1019–1024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chung TW, Moon SK, Chang YC, Ko JH, Lee
YC, Cho G, Kim SH, Kim JG and Kim CH: Novel and therapeutic effect
of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma
cells: Complete regression of hepatoma growth and metastasis by
dual mechanism. FASEB J. 18:1670–1681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hong S, Park KK, Magae J, Ando K, Lee TS,
Kwon TK, Kwak JY, Kim CH and Chang YC: Ascochlorin inhibits matrix
metalloproteinase-9 expression by suppressing activator
protein-1-mediated gene expression through the ERK1/2 signaling
pathway: Inhibitory effects of ascochlorin on the invasion of renal
carcinoma cells. J Biol Chem. 280:25202–25209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH,
Kim WK and Kim HS: Curcumin suppresses phorbol ester-induced matrix
metalloproteinase-9 expression by inhibiting the PKC to MAPK
signaling pathways in human astroglioma cells. Biochem Biophys Res
Commun. 335:1017–1025. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H
and Saiki I: Prevention of intrahepatic metastasis by curcumin in
an orthotopic implantation model. Oncology. 65:250–258. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Reyes-Ortiz CA, Eschbach K, Zhang DD and
Goodwin JS: Neighborhood composition and cancer among hispanics:
Tumor stage and size at time of diagnosis. Cancer Epidemiol
Biomarkers Prev. 17:2931–2936. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Howlader N, Noone AM, Krapcho M, Miller D,
Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z and Mariotto A:
SEER cancer statistics review, 1975–2014. National Cancer
Institute; Bethesda, MD: 2017
|
|
32
|
Polyak K: Heterogeneity in breast cancer.
J Clin Invest. 121:3786–3788. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Neophytou C, Boutsikos P and Papageorgis
P: Molecular mechanisms and emerging therapeutic targets of
triple-negative breast cancer metastasis. Front Oncol. 8:312018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li DM and Feng YM: Signaling mechanism of
cell adhesion molecules in breast cancer metastasis: Potential
therapeutic targets. Breast Cancer Res Treat. 128:7–21. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scorilas A, Karameris A, Arnogiannaki N,
Ardavanis A, Bassilopoulos P, Trangas T and Talieri M:
Overexpression of matrix-metalloproteinase-9 in human breast
cancer: A potential favourable indicator in node-negative patients.
Br J Cancer. 84:1488–1496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park SK, Hwang YS, Park KK, Park HJ, Seo
JY and Chung WY: Kalopanaxsaponin A inhibits PMA-induced invasion
by reducing matrix metalloproteinase-9 via PI3K/Akt- and
PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Carcinogenesis. 30:1225–1233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Weng CJ, Chau CF, Hsieh YS, Yang SF and
Yen GC: Lucidenic acid inhibits PMA-induced invasion of human
hepatoma cells through inactivating MAPK/ERK signal transduction
pathway and reducing binding activities of NF-kappaB and AP-1.
Carcinogenesis. 29:147–156. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eberhardt W, Huwiler A, Beck KF, Walpen S
and Pfeilschifter J: Amplification of IL-1 beta-induced matrix
metalloproteinase-9 expression by superoxide in rat glomerular
mesangial cells is mediated by increased activities of NF-kappa B
and activating protein-1 and involves activation of the
mitogen-activated protein kinase pathways. J Immunol.
165:5788–5797. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yao J, Xiong S, Klos K, Nguyen N, Grijalva
R, Li P and Yu D: Multiple signaling pathways involved in
activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1
in human breast cancer cells. Oncogene. 20:8066–8074. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Madrid LV, Mayo MW, Reuther JY and Baldwin
AS Jr: Akt stimulates the transactivation potential of the RelA/p65
Subunit of NF-kappa B through utilization of the Ikappa B kinase
and activation of the mitogen-activated protein kinase p38. J Biol
Chem. 276:18934–18940. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saja K, Babu MS, Karunagaran D and
Sudhakaran PR: Anti-inflammatory effect of curcumin involves
downregulation of MMP-9 in blood mononuclear cells. Int
Immunopharmacol. 7:1659–1667. 2007. View Article : Google Scholar : PubMed/NCBI
|
